Vincerx Pharma Inc (VINC)
0.2982
-0.03
(-8.25%)
USD |
NASDAQ |
Nov 14, 12:20
Vincerx Pharma Total Assets (Quarterly): 21.53M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 21.53M |
| March 31, 2024 | 11.08M |
| December 31, 2023 | 18.22M |
| September 30, 2023 | 26.28M |
| June 30, 2023 | 35.28M |
| March 31, 2023 | 47.45M |
| December 31, 2022 | 59.29M |
| September 30, 2022 | 72.38M |
| Date | Value |
|---|---|
| June 30, 2022 | 87.74M |
| March 31, 2022 | 103.88M |
| December 31, 2021 | 117.68M |
| September 30, 2021 | 129.42M |
| June 30, 2021 | 91.14M |
| March 31, 2021 | 58.00M |
| December 31, 2020 | 63.19M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
11.08M
Minimum
Mar 2024
129.42M
Maximum
Sep 2021
62.84M
Average
59.29M
Median
Dec 2022
Total Assets (Quarterly) Benchmarks
| CEL-SCI Corp | 24.07M |
| AIM ImmunoTech Inc | 15.72M |
| IGC Pharma Inc | 10.59M |
| NovaBay Pharmaceuticals Inc | 3.925M |
| Protalix BioTherapeutics Inc | 91.54M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 6.079M |
| Shareholders Equity (Quarterly) | 15.45M |